Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium®'

Media coverage

• Title	Intensity Therapeutics Reports Promising Early Efficacy Results Using INT230-6 as a Monotherapy or in Combination with Pembrolizumab in Metastatic Breast Cancer at the 2021 San Antonio Breast Cancer Symposium®'
  Media name/outlet	MENAFN -Press Releases (English)
  Country/Territory	Jordan
  Date	12/10/21
  Persons	Anthony J. Olszanski